Frequency and characteristics of HIV-associated sensory neuropathy among HIV patients in Bangkok, Thailand

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 4, 2008, Pages 456-458

  Sithinamsuwan, Pasiri ^a   Punthanamongkol, Sirichai ^a   Valcour, Victor ^b,c   Onsanit, Satrirat ^a   Nidhinandana, Samart ^a   Thitivichianlert, Sataporn ^a   Shikuma, Cecilia ^b  

^a PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ANTIRETROVIRUS AGENT; STAVUDINE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANAMNESIS; BODY MASS; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED SENSORY NEUROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LETTER; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; NEUROTOXICITY; PARESTHESIA; PRIORITY JOURNAL; SENSORY NEUROPATHY; THAILAND;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; RNA, VIRAL; THAILAND;

EID: 57649112723     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318186eb03     Document Type: Letter

References (14)

1. Verma S, Estanislao L, Simpson D. HIV-associated neuropathic pain: epidemiology, pathophysiology and management. CNS Drugs. 2005;19:325-334.
2. So YT, Holtzman DM, Abrams DI, et al. Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. Arch Neurol. 1988;45:945-948.
3. Childs EA, Lyles RH, Seines OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. 1999;52:607-613.
4. Cherry CL, Skolasky RL, Lal L, et al. Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology. 2006;66:867-873.
5. Boulle A, Orrel C, Kaplan R, et al. Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Antivir Ther. 2007;12:753-760.
6. Hawkins C, Achenbach C, Fryda W, et al. Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya. J Acquir Immune Defic Syndr. 2007;45:304-310.
7. Getahun A, Tansuphasawadikul S, Desakorn V, et al. Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infection. J Med Assoc Thai. 2006;89:1472-1478.
8. Wright E, Brew B, Lal L, et al. High prevalence of neurocognitive impairment, symptomatic peripheral neuropathy and depression in HIV infected outpatients within the Asia Pacific Region: findings fo the Asia Pacific NeuroAIDS Consortium (APNAC) study. Paper presented at: Conference on Retroviruses and Opportunistic Infections; February 5-8, 2006; Denver, CO. Poster number E-130.
9. Simpson DM, Kitch D, Evans SR, et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology. 2006;66:1679-1687.
10. Valcour VG, Sithinamsuwan P, Nidhinandana S, et al. Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection. Neurology. 2007;68:525-527.
11. Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology. 1994;44:1892-1900.
12. Moyle GJ, Sadler M. Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management. Drug Saf. 1998; 19:481-494.
13. Kieburtz KD, Seidlin M, Lambert JS, et al. Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine. J Acquir Immune Defic Syndr. 1992;5:60-64.
14. Lichtenstein KA, Armon C, Baron A, et al. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis. 2005;40:148-157.